Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis

Franziska Herster1, Zsofia Bittner1, Nathan K Archer2

  • 1Department of Immunology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.

Nature Communications
|January 9, 2020
PubMed

Insights

Psoriasis inflammation involves neutrophils releasing neutrophil extracellular traps (NETs). NET-associated RNA (naRNA) complexed with LL37 triggers a self-propagating inflammatory cycle, independent of DNA, driving chronic skin disease.

Area of Science:

  • Immunology
  • Dermatology
  • Molecular Biology

Background:

  • Psoriasis is an inflammatory skin condition characterized by neutrophil infiltration and LL37.
  • LL37 complexed with nucleic acids is implicated in disease exacerbation, but the nucleic acid source is unknown.
  • Neutrophil extracellular traps (NETs) are a key feature of psoriasis.

Purpose of the Study:

  • To investigate the role of nucleic acids in psoriasis-driven inflammation.
  • To identify the source and function of nucleic acids within NETs in psoriasis.
  • To elucidate the mechanism of self-propagating inflammation in psoriasis.

Main Methods:

  • Analysis of primary murine and human neutrophils.
  • In vitro and in vivo experiments assessing cytokine and NET release.
  • Investigation of Toll-like receptor (TLR) involvement.

Main Results:

  • Neutrophils mount a self-propagating response involving NETs and cytokines, independent of DNA.
  • NET-associated RNA (naRNA), not DNA, complexed with LL37 triggers TLR8/TLR13-mediated inflammation.
  • Psoriatic skin contains abundant naRNA, unlike healthy skin.
  • Transfer of NETs induces further NET release and inflammation.

Conclusions:

  • NET-associated RNA (naRNA) is a key driver of psoriasis inflammation.
  • A self-propagating cycle of naRNA-LL37 complex-mediated NETosis contributes to chronic inflammation in psoriasis.
  • Targeting naRNA may offer a novel therapeutic strategy for psoriasis.